Loading clinical trials...
Loading clinical trials...
The Purpose of this trial is: * to determine complete response rate (CRR) after six cycles of chemotherapy * to determine complete remission rate (CR/CRr) as final treatment outcome after completion of treatment
Age
18 - 60 years
Sex
ALL
Healthy Volunteers
No
1st Dept. of Medicine, Cologne University Hospital
Cologne, Germany
Start Date
October 1, 2012
Primary Completion Date
March 1, 2014
Completion Date
December 1, 2017
Last Updated
October 29, 2018
100
ESTIMATED participants
Etoposide
DRUG
Cyclophosphamide
DRUG
Doxorubicin
DRUG
Prednisone
DRUG
Procarbazine
DRUG
Dexamethasone
DRUG
Dacarbazine
DRUG
Brentuximab Vedotin
DRUG
Lead Sponsor
University of Cologne
NCT05529069
NCT06189391
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05006716